Loading clinical trials...
Loading clinical trials...
A Randomized, 24-Week Treatment, Double-blind, Placebo-controlled Efficacy and Safety Study of Dupilumab 300 mg Every Other Week, in Patients With Bilateral Nasal Polyposis on a Background Therapy With Intranasal Corticosteroids
Conditions
Interventions
Dupilumab SAR231893 (REGN668)
Placebo
+1 more
Locations
76
United States
Investigational Site Number 8400009
Long Beach, California, United States
Investigational Site Number 8400004
Orange, California, United States
Investigational Site Number 8400014
San Diego, California, United States
Investigational Site Number 8400002
Stockton, California, United States
Investigational Site Number 8400016
Centennial, Colorado, United States
Investigational Site Number 8400013
Tampa, Florida, United States
Start Date
December 5, 2016
Primary Completion Date
July 5, 2018
Completion Date
July 5, 2018
Last Updated
July 25, 2019
Lead Sponsor
Sanofi
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions